Breaking News on Contract Research, Manufacturing & Clinical Trials

Headlines > October 2012

« Previous month Next month »

Lonza cuts jobs at Visp and plans to review productivity at other sites

31-Oct-2012 - Lonza says it will cut jobs at its facility in Visp, Switzerland and that it may enact ‘similar productivity improvement programmes’ at other facilities. 

update #2

East coast CMOs relatively unscathed by Superstorm Sandy

31-Oct-2012 - The full impact of Superstorm Sandy is still being assessed, but early reports suggest that the East coast contract manufacturing industry has escaped relatively unscathed.

News in brief

SAFC wins preformulation services deal

31-Oct-2012 - SAFC will provide pre-formulation services for South Korea-based NSAID developer CrystalGenomics.

Cyprotex teams with Pfizer on predictive tox project

30-Oct-2012 - Cyprotex has signed an 18-month collaboration with US drug giant Pfizer focused on predictive in-vitro toxicology in preclinical development.

Biotrial to buy Warnex’s remaining biz for $6m; plans US clinical unit

30-Oct-2012 - French contract research organisation (CRO) Biotrial will buy Warnex’s bioanalytical services business for C$6m before the end of the year.

Patheon to buy Banner Pharmacaps for $255m

29-Oct-2012 - Canadian CMO Patheon will buy softgel specialist Banner Pharmacaps, moving forward with its plan to build in the oral dose delivery sector.

Lonza tweaks E.coli expression system; denies takeover rumours

29-Oct-2012 - Lonza claims a new selection technology to its microbial protein expression system will improve yields and boost efficiency.

News from Lonza, DSM, Ark and AMRI

29-Oct-2012 - presents a roundup of contract manufacturing news with deals for Lonza, DSM and Ark Therapeutics and an expanded agreement with Shire for AMRI.  

News from CPhI

Cobra Biologics talks recent fill finish acquisition and future growth plans

25-Oct-2012 - CMO Cobra Biologics says North America is an obvious place to look at for a facility acquisition.

News for CPhI

New import laws spur hopes for reduced trial start-up time in Ukraine

25-Oct-2012 - Ukraine hopes changes to import laws will help cut trial start-up time from six month to 45 days.

News from Quintiles, AMRI and PDI – People on the move

25-Oct-2012 - presents its weekly round-up of the latest appointments within the industry, including news from Quintiles, AMRI and PDI.

Fujifilm and Piramal team on ADC manufacturing

24-Oct-2012 - Fujifilm Diosynth Biotechnologies has partnered with Piramal Healthcare on development and manufacture of ADCs.

Genetic 'placebo response' marker has trial design implications, say researchers

24-Oct-2012 - Discovery of the genetic basis for the placebo effect in IBS patients has wider implications for protocol design and trials of personalised medicines say researchers.

Quintiles to conduct its first global trial using Indonesian patients

24-Oct-2012 - Quintiles has established roots in Indonesia through a new partnership with Prodia.

News from CPhI

Penn Pharma in talks with the big boys over new facility

24-Oct-2012 - Penn Pharma is in talks with a number of “big players” over its upcoming high containment oral solid dose facility.

EMA publishes guidance on trial data publishing

23-Oct-2012 - The EMA has issued new guidance on the publication of clinical trial results as part of an effort to make such data publicly available.

News in brief

DRAP sets up committee to solve price restructuring woes with CMOs

23-Oct-2012 - The Drug Regulatory Authority of Pakistan has set up a committee to resolve registration and licensing issues with local contract manufacturers.

News from AAPS

Xcelience plans EU clinical trial supply expansion after opening new US plant

23-Oct-2012 - Xcelience is shopping for a European distributor after opening a new clinical trial supply facility in the US.

Former Lonza biologics CSO joins Cobra board

23-Oct-2012 - Cobra Biologics says former Lonza biopharmaceutical science officer brings strategic insight, process development and manufacturing expertise.

update - audio available

Catalent says sharing with industry will not dull competetive edge

22-Oct-2012 - Catalent says making its technology available to industry will not affect its competitive edge.

Wuxi opens biologics plant with JV partner AstraZeneca in attendance

22-Oct-2012 - Wuxi AppTec has opened a biologics manufacturing facility that will play a key role in its recent accord with Anglo-Swedish drugmaker AstraZeneca.

SNBL USA gets animal welfare accreditation

22-Oct-2012 - Preclinical services firm SNBL USA has gained AAALAC accreditation for animal research programs at its sites in Everett, Washington and Alice, Texas.

Ben Venue restarts production; Janssen says Doxil available soon

18-Oct-2012 - US CMO Ben Venue has restarted 'limited drug manufacturing' at its plant in Bedford, Ohio, but does not expect to start shipping product for several months.

News in brief

Catalent aims to boost drug delivery through industry-academia partnership

18-Oct-2012 - Catalent has established a new institute in a bid to advance drug delivery by creating links between industry and academia.

News from Wolters, Advanced Clinical and BIA – People on the move

18-Oct-2012 - presents its weekly round-up of the latest changes, faces and places in the pharma services sector, including news from Wolters, Advanced Clinical and BIA.

« Previous month Next month »

Key Industry Events


Access all events listing

Our events, Shows & Conferences...